Training the microbiota to increase immune checkpoint blockade and to reduce toxicity
- 23 February 2023
- journal article
- research article
- Published by Wiley in European Journal of Immunology
- Vol. 53 (11) , e2250183
Abstract
There is no doubt that immunotherapy, particularly immune checkpoint blockade (ICB), has drastically improved treatment of metastatic cancer patients. Microbiota composition has been proposed to be one of the reasons for failure or success. ICB works via the activation or reactivation of T cells that are “switched off” by tumor cells or by the tumor microenvironment. Even advanced metastatic disease, previously considered as untreatable, can benefit from cancer immunotherapy. However, still a good proportion of patients does not respond to therapy or acquires resistance during treatment. Some genera or species of bacteria have been associated with treatment response or toxicity, but as the composition of the microbiota is not static, rather, it is very dynamic there is promise that by changing the microbiota composition, or by harnessing the microbiota ‘secrete’ tricks, one can improve treatment efficacy or reduce toxicity. Several players, including diet, prebiotics, probiotics, and postbiotics, have been proposed to shape the microbiota. In this minireview, we summarize very recent data on how to train the microbiota to increase ICB efficacy and reduce toxicity.Keywords
This publication has 40 references indexed in Scilit:
- Endogenous murine microbiota member Faecalibaculum rodentium and its human homologue protect from intestinal tumour growthNature Microbiology, 2020
- The commensal microbiome is associated with anti–PD-1 efficacy in metastatic melanoma patientsScience, 2018
- Gut microbiome modulates response to anti–PD-1 immunotherapy in melanoma patientsScience, 2018
- Metagenomic Shotgun Sequencing and Unbiased Metabolomic Profiling Identify Specific Human Gut Microbiota and Metabolites Associated with Immune Checkpoint Therapy Efficacy in Melanoma PatientsNeoplasia, 2017
- Modulation of the Gastrointestinal Microbiome with Nondigestible Fermentable Carbohydrates To Improve Human HealthMicrobiology Spectrum, 2017
- Primary, Adaptive, and Acquired Resistance to Cancer ImmunotherapyCell, 2017
- Intestinal microbiome analyses identify melanoma patients at risk for checkpoint-blockade-induced colitisNature Communications, 2016
- A gut-vascular barrier controls the systemic dissemination of bacteriaScience, 2015
- Postbiotics: what else?Beneficial Microbes, 2013
- Should probiotics be tested on ex vivo organ culture models?Gut Microbes, 2012